|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee YG, Macoska JA, Korenchuk S and Pienta
KJ: MIM, a potential metastasis suppressor gene in bladder cancer.
Neoplasia. 4:291–294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nixdorf S, Grimm MO, Loberg R, Marreiros
A, Russell PJ, Pienta KJ and Jackson P: Expression and regulation
of MIM (Missing In Metastasis), a novel putative metastasis
suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer
Lett. 215:209–220. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loberg RD, Neeley CK, Adam-Day LL, Fridman
Y, St John LN, Nixdorf S, Jackson P, Kalikin LM and Pienta KJ:
Differential expression analysis of MIM (MTSS1) splice variants and
a functional role of MIM in prostate cancer cell biology. Int J
Oncol. 26:1699–1705. 2005.PubMed/NCBI
|
|
7
|
Du P, Ye L, Li H, Yang Y and Jiang WG: The
tumour suppressive role of metastasis suppressor-1, MTSS1, in human
kidney cancer, a possible connection with the SHH pathway. J Exp
Ther Oncol. 10:91–99. 2012.
|
|
8
|
Liu K, Wang G, Ding H, Chen Y, Yu G and
Wang J: Downregulation of metastasis suppressor 1 (MTSS1) is
associated with nodal metastasis and poor outcome in Chinese
patients with gastric cancer. BMC Cancer. 10:4282010. View Article : Google Scholar
|
|
9
|
Parr C and Jiang WG: Metastasis suppressor
1 (MTSS1) demonstrates prognostic value and anti-metastatic
properties in breast cancer. Eur J Cancer. 45:1673–1683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma S, Guan XY, Lee TK and Chan KW:
Clinicopathological significance of missing in metastasis B
expression in hepato-cellular carcinoma. Hum Pathol. 38:1201–1206.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamagishi A, Masuda M, Ohki T, Onishi H
and Mochizuki N: A novel actin bundling/filopodium-forming domain
conserved in insulin receptor tyrosine kinase substrate p53 and
missing in metastasis protein. J Biol Chem. 279:14929–14936. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mattila PK, Salminen M, Yamashiro T and
Lappalainen P: Mouse MIM, a tissue-specific regulator of
cytoskeletal dynamics, interacts with ATP-actin monomers through
its C-terminal WH2 domain. J Biol Chem. 278:8452–8459. 2003.
View Article : Google Scholar
|
|
13
|
Woodings JA, Sharp SJ and Machesky LM:
MIM-B, a putative metastasis suppressor protein, binds to actin and
to protein tyrosine phosphatase delta. Biochem J. 371:463–471.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Liu J, Segura MF, Shao C, Lee P,
Gong Y, Hernando E and Wei JJ: MiR182 overexpression in
tumorigenesis of high-grade ovarian papillary serous carcinoma. J
Pathol. 228:204–215. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang WG, Davies G, Martin TA, Parr C,
Watkins G, Mason MD and Mansel RE: Expression of membrane type-1
matrix metal-loproteinase, MT1-MMP in human breast cancer and its
impact on invasiveness of breast cancer cells. Int J Mol Med.
17:583–590. 2006.PubMed/NCBI
|
|
16
|
Jiang WG, Davies G, Martin TA, Parr C,
Watkins G, Mason MD, Mokbel K and Mansel RE: Targeting matrilysin
and its impact on tumor growth in vivo: The potential implications
in breast cancer therapy. Clin Cancer Res. 11:6012–6019. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang WG, Hiscox S, Singhrao SK, Nakamura
T, Puntis MC and Hallett MB: Inhibition of HGF/SF-induced membrane
ruffling and cell motility by transient elevation of cytosolic free
Ca2+. Exp Cell Res. 220:424–433. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang WG, Hiscox S, Hallett MB, Horrobin
DF, Scott C and Puntis MCA: Inhibition of invasion and motility of
human colon cancer cells by gamma linolenic acid. Br J Cancer.
71:744–752. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang WG, Martin TA, Lewis-Russell JM,
Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in
human breast cancer, the impact on cellular migration and clinical
outcome. Mol Cancer. 7:71–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Onda T and Yoshikawa H: Neoadjuvant
chemotherapy for advanced ovarian cancer: Overview of outcomes and
unanswered questions. Expert Rev Anticancer Ther. 11:1053–1067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kurman RJ, Visvanathan K, Roden R, Wu TC
and Shih IeM: Early detection and treatment of ovarian cancer:
Shifting from early stage to minimal volume of disease based on a
new model of carcinogenesis. Am J Obstet Gynecol. 198:351–356.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang JL, Ow KT, Russell PJ, Ham JM and
Crowe PJ: Higher expression of oncoproteins c-myc, c-erb B-2/neu,
PCNA, and p53 in metastasizing colorectal cancer than in
nonmetastasizing tumors. Ann Surg Oncol. 3:574–579. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goncharuk VN, del-Rosario A, Kren L, Anwar
S, Sheehan CE, Carlson JA and Ross JS: Co-downregulation of PTEN,
KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in
non-small cell lung cancer. Ann Diagn Pathol. 8:6–16. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mustafa N, Martin TA and Jiang WG:
Metastasis tumour suppressor-1 and the aggressiveness of prostate
cancer cells. Exp Ther Med. 2:157–162. 2011.PubMed/NCBI
|
|
25
|
Dawson JC, Timpson P, Kalna G and Machesky
LM: Mtss1 regulates epidermal growth factor signaling in head and
neck squamous carcinoma cells. Oncogene. 31:1781–1793. 2012.
View Article : Google Scholar
|
|
26
|
Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang
Y, Zhang L and Jiang WG: The impact of metastasis suppressor-1,
MTSS1, on oesophageal squamous cell carcinoma and its clinical
significance. J Transl Med. 9:952011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dawson JC, Bruche S, Spence HJ, Braga VM
and Machesky LM: Mtss1 promotes cell-cell junction assembly and
stability through the small GTPase Rac1. PLoS One. 7:e311412012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu
X, Zhao Z, Kong KL, Dong S, Song Y, Chan THM and Guan XY: MTSS1, a
novel target of DNA methyltransferase 3B, functions as a tumor
suppressor in hepatocellular carcinoma. Oncogene. 31:2298–2308.
2012. View Article : Google Scholar
|
|
29
|
Du P, Ye L, Ruge F, Yang Y and Jiang WG:
Metastasis suppressor-1, MTSS1, acts as a putative tumour
suppressor in human bladder cancer. Anticancer Res. 31:3205–3212.
2011.PubMed/NCBI
|
|
30
|
Callahan CA, Ofstad T, Horng L, Wang JK,
Zhen HH, Coulombe PA and Oro AE: MIM/BEG4, a Sonic
hedgehog-responsive gene that potentiates Gli-dependent
transcription. Genes Dev. 18:2724–2729. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie F, Ye L, Ta M, Zhang L and Jiang WG:
MTSS1: A multi-functional protein and its role in cancer invasion
and metastasis. Front Biosci (Schol Ed). 3:621–631. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhong J, Shaik S, Wan L, Tron AE, Wang Z,
Sun L, Inuzuka H and Wei W: SCF β-TRCP targets MTSS1 for
ubiquitination-mediated destruction to regulate cancer cell
proliferation and migration. Oncotarget. 4:2339–2353. 2013.
View Article : Google Scholar : PubMed/NCBI
|
